Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 254

1.

The epidemiology of antiretroviral drug resistance among drug-naive HIV-1-infected persons in 10 US cities.

Weinstock HS, Zaidi I, Heneine W, Bennett D, Garcia-Lerma JG, Douglas JM Jr, LaLota M, Dickinson G, Schwarcz S, Torian L, Wendell D, Paul S, Goza GA, Ruiz J, Boyett B, Kaplan JE.

J Infect Dis. 2004 Jun 15;189(12):2174-80. Epub 2004 May 21.

PMID:
15181563
[PubMed - indexed for MEDLINE]
Free Article
2.

Prevalence of antiretroviral drug resistance and resistance-associated mutations in antiretroviral therapy-naïve HIV-infected individuals from 40 United States cities.

Ross L, Lim ML, Liao Q, Wine B, Rodriguez AE, Weinberg W, Shaefer M.

HIV Clin Trials. 2007 Jan-Feb;8(1):1-8.

PMID:
17434843
[PubMed - indexed for MEDLINE]
Free Article
3.

Prevalence of antiretroviral drug resistance mutations in chronically HIV-infected, treatment-naive patients: implications for routine resistance screening before initiation of antiretroviral therapy.

Novak RM, Chen L, MacArthur RD, Baxter JD, Huppler Hullsiek K, Peng G, Xiang Y, Henely C, Schmetter B, Uy J, van den Berg-Wolf M, Kozal M; Terry Beirn Community Programs for Clinical Research on AIDS 058 Study Team.

Clin Infect Dis. 2005 Feb 1;40(3):468-74. Epub 2005 Jan 10.

PMID:
15668873
[PubMed - indexed for MEDLINE]
Free Article
4.

Primary drug resistance in antiretroviral-naïve injection drug users.

Tossonian HK, Raffa JD, Grebely J, Viljoen M, Mead A, Khara M, McLean M, Krishnamurthy A, DeVlaming S, Conway B.

Int J Infect Dis. 2009 Sep;13(5):577-83. doi: 10.1016/j.ijid.2008.08.028. Epub 2008 Dec 25.

PMID:
19111493
[PubMed - indexed for MEDLINE]
Free Article
5.

Prevalence of HIV-1 resistant to antiretroviral drugs in 81 individuals newly infected by sexual contact or injecting drug use. Investigators of the Quebec Primary Infection Study.

Salomon H, Wainberg MA, Brenner B, Quan Y, Rouleau D, Coté P, LeBlanc R, Lefebvre E, Spira B, Tsoukas C, Sekaly RP, Conway B, Mayers D, Routy JP.

AIDS. 2000 Jan 28;14(2):F17-23.

PMID:
10708278
[PubMed - indexed for MEDLINE]
6.

The prevalence of resistance-associated mutations to protease and reverse transcriptase inhibitors in treatment-naïve (HIV1)-infected individuals in Casablanca, Morocco.

Bakhouch K, Oulad-Lahcen A, Bensghir R, Blaghen M, Elfilali KM, Ezzikouri S, Abidi O, Hassar M, Wakrim L.

J Infect Dev Ctries. 2009 Jun 1;3(5):380-91.

PMID:
19759509
[PubMed - indexed for MEDLINE]
Free Article
7.

Low prevalence of antiretroviral resistance among persons recently infected with human immunodeficiency virus in two US cities.

Sullivan PS, Buskin SE, Turner JH, Cheingsong R, Saekhou A, Kalish ML, Jones JL, Respess R, Kovacs A, Heneine W.

Int J STD AIDS. 2002 Aug;13(8):554-8.

PMID:
12194739
[PubMed - indexed for MEDLINE]
8.

Prevalence of genotypic and phenotypic resistance to anti-retroviral drugs in a cohort of therapy-naïve HIV-1 infected US military personnel.

Wegner SA, Brodine SK, Mascola JR, Tasker SA, Shaffer RA, Starkey MJ, Barile A, Martin GJ, Aronson N, Emmons WW, Stephan K, Bloor S, Vingerhoets J, Hertogs K, Larder B.

AIDS. 2000 May 26;14(8):1009-15.

PMID:
10853983
[PubMed - indexed for MEDLINE]
9.

Prevalence of resistance mutations in antiretroviral-naive chronically HIV-infected patients in 1998: a French nationwide study.

Descamps D, Calvez V, Izopet J, Buffet-Janvresse C, Schmuck A, Colson P, Ruffault A, Maillard A, Masquelier B, Cottalorda J, Harzic M, Brun-Vézinet F, Costagliola D; ANRS Antiretroviral Resistance Study Group.

AIDS. 2001 Sep 28;15(14):1777-82.

PMID:
11579238
[PubMed - indexed for MEDLINE]
10.

Antiretroviral resistance among HIV-infected persons who have died in British Columbia, in the era of modern antiretroviral therapy.

Recsky MA, Brumme ZL, Chan KJ, Wynhoven B, Yip B, Dong WW, Heath KV, Montaner JS, Levy AR, Hogg RS, Harrigan PR.

J Infect Dis. 2004 Jul 15;190(2):285-92. Epub 2004 Jun 11.

PMID:
15216463
[PubMed - indexed for MEDLINE]
Free Article
11.

Prevalence of mutations associated with reduced antiretroviral drug susceptibility among human immunodeficiency virus type 1 seroconverters in the United States, 1993-1998.

Weinstock H, Respess R, Heneine W, Petropoulos CJ, Hellmann NS, Luo CC, Pau CP, Woods T, Gwinn M, Kaplan J.

J Infect Dis. 2000 Jul;182(1):330-3. Epub 2000 Jun 13.

PMID:
10882618
[PubMed - indexed for MEDLINE]
Free Article
12.

Prevalence of HIV-1 drug resistance mutations among Spanish prison inmates.

García-Guerrero J, Sáiz de la Hoya P, Portilla J, Marco A, Sánchez-Payá J, Moreno S; Estudio de Resistencias en Prisiones Group.

Eur J Clin Microbiol Infect Dis. 2006 Nov;25(11):695-701.

PMID:
17043836
[PubMed - indexed for MEDLINE]
13.

Primary antiretroviral drug resistance among HIV type 1-infected individuals in Brazil.

Sprinz E, Netto EM, Patelli M, Lima JS, Furtado JJ, da Eira M, Zajdenverg R, Madruga JV, Lewi DS, Machado AA, Pedro RJ, Soares MA.

AIDS Res Hum Retroviruses. 2009 Sep;25(9):861-7. doi: 10.1089/aid.2009.0012. Erratum in: AIDS Res Hum Retroviruses. 2009 Oct;25(10):1055. Patelli, Maria [added]; Lima, Maria Patelli J S [corrected to Lima, J S]; Machado, Alcyone A [added].

PMID:
19689190
[PubMed - indexed for MEDLINE]
14.

Genotypic resistance of antiretroviral drugs among drug-naive HIV type 1 patients with the background of long-term access-easy zidovudine therapy.

Park SW, Kim HB, Choi YJ, Kim NJ, Oh MD, Choe KW.

AIDS Res Hum Retroviruses. 2003 Nov;19(11):1039-43.

PMID:
14686324
[PubMed - indexed for MEDLINE]
15.

Prevalence of drug resistance mutations in Spain among both naive and pretreated patients.

Soriano V.

Antivir Ther. 1999;4 Suppl 3:57-63. Review.

PMID:
16021872
[PubMed - indexed for MEDLINE]
16.

Prevalence of drug-resistant human immunodeficiency virus type 1 in therapy-naive patients and usefulness of genotype testing.

Ibe S, Hotta N, Takeo U, Tawada Y, Mamiya N, Yamanaka K, Utsumi M, Kaneda T.

Microbiol Immunol. 2003;47(7):499-505.

PMID:
12953843
[PubMed - indexed for MEDLINE]
17.

Testing genotypic and phenotypic resistance in human immunodeficiency virus type 1 isolates of clade B and other clades from children failing antiretroviral therapy.

Brindeiro PA, Brindeiro RM, Mortensen C, Hertogs K, De Vroey V, Rubini NP, Sion FS, De Sá CA, Machado DM, Succi RC, Tanuri A.

J Clin Microbiol. 2002 Dec;40(12):4512-9.

PMID:
12454144
[PubMed - indexed for MEDLINE]
Free PMC Article
18.

Short communication: low prevalence of genotypic drug resistance mutations among antiretroviral-naive HIV type 1 patients in Malaysia.

Tee KK, Kamarulzaman A, Ng KP.

AIDS Res Hum Retroviruses. 2006 Feb;22(2):121-4.

PMID:
16478392
[PubMed - indexed for MEDLINE]
19.

Prevalence of nonnucleoside reverse transcriptase inhibitor (NNRTI) resistance-associated mutations and polymorphisms in NNRTI-naïve HIV-infected patients.

Clevenbergh P, Cua E, Dam E, Durant J, Schmit JC, Boulme R, Cottalorda J, Beyou A, Schapiro JM, Clavel F, Dellamonica P.

HIV Clin Trials. 2002 Jan-Feb;3(1):36-44.

PMID:
11819184
[PubMed - indexed for MEDLINE]
20.

Prevalence of drug resistance and newly recognised treatment-related substitutions in the HIV-1 reverse transcriptase and protease genes from HIV-positive patients naïve for anti-retrovirals.

Torti C, Bono L, Gargiulo F, Uccelli MC, Quiros-Roldan E, Patroni A, Paraninfo G, Tirelli V, Manca N, De Francesco MA, Perandin F, Carosi G.

Clin Microbiol Infect. 2004 Sep;10(9):826-30.

PMID:
15355414
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk